Presented by
Mark Sculpher, Neil Hawkins
and members of the HTA SIG
This 2-day course will provide an introduction to the methods of health technology assessment. There will be a focus on how to estimate the costs and benefits of new interventions and analysis undertaken to support decisions about whether new interventions should be funded by health systems. The first day will include sessions on policy context and basic economic evaluation methods, as well as lectures on health measurement and valuation for HTA, evidence synthesis and decision analysis. There will also be exercises to confirm participants’ understanding of key concepts. The second day will focus on sharing case studies and discussing key statistical challenges in HTA. Attendees will be encouraged to share their own HTA experiences.
The following topics will be covered: • HTA Policy
• Methods of economic evaluation
• Critical review of HTA publications
• Evidence synthesis
• Measuring and valuing health
• HTA decision models
• Industry HTA case studies
• Key statistical challenges in HTA
Course runs from: 10:00 – 18:00 (registration from 9:30) on Day 1
09:00 – 15:30 on Day 2.
Registration
Before 23rd December 2016
PSI Members
£495 + VAT
Non- Members
£570 + VAT (includes PSI membership for 1 year)
After 23rd December 2016
PSI Members
£595 +VAT
Non - Members
£670 + VAT (includes PSI membership for 1 year)
Registration costs (includes lunch and refreshments)
PSI are holding a limited number of hotel rooms at an extra cost until the 23rd December 2016 which will be allocated on a first come first served basis. Please contact the PSI Secretariat for more information.
Registration is now closed. Please contact the PSI Secretariat for late registrations.
Scientific Meetings
Health Technology Assessment (HTA) Training Course
Presented by
Mark Sculpher, Neil Hawkins
and members of the HTA SIG
This 2-day course will provide an introduction to the methods of health technology assessment. There will be a focus on how to estimate the costs and benefits of new interventions and analysis undertaken to support decisions about whether new interventions should be funded by health systems. The first day will include sessions on policy context and basic economic evaluation methods, as well as lectures on health measurement and valuation for HTA, evidence synthesis and decision analysis. There will also be exercises to confirm participants’ understanding of key concepts. The second day will focus on sharing case studies and discussing key statistical challenges in HTA. Attendees will be encouraged to share their own HTA experiences.
The following topics will be covered: • HTA Policy
• Methods of economic evaluation
• Critical review of HTA publications
• Evidence synthesis
• Measuring and valuing health
• HTA decision models
• Industry HTA case studies
• Key statistical challenges in HTA
Course runs from: 10:00 – 18:00 (registration from 9:30) on Day 1
09:00 – 15:30 on Day 2.
Registration
Before 23rd December 2016
PSI Members
£495 + VAT
Non- Members
£570 + VAT (includes PSI membership for 1 year)
After 23rd December 2016
PSI Members
£595 +VAT
Non - Members
£670 + VAT (includes PSI membership for 1 year)
Registration costs (includes lunch and refreshments)
PSI are holding a limited number of hotel rooms at an extra cost until the 23rd December 2016 which will be allocated on a first come first served basis. Please contact the PSI Secretariat for more information.
Registration is now closed. Please contact the PSI Secretariat for late registrations.
Training Courses
Health Technology Assessment (HTA) Training Course
Presented by
Mark Sculpher, Neil Hawkins
and members of the HTA SIG
This 2-day course will provide an introduction to the methods of health technology assessment. There will be a focus on how to estimate the costs and benefits of new interventions and analysis undertaken to support decisions about whether new interventions should be funded by health systems. The first day will include sessions on policy context and basic economic evaluation methods, as well as lectures on health measurement and valuation for HTA, evidence synthesis and decision analysis. There will also be exercises to confirm participants’ understanding of key concepts. The second day will focus on sharing case studies and discussing key statistical challenges in HTA. Attendees will be encouraged to share their own HTA experiences.
The following topics will be covered: • HTA Policy
• Methods of economic evaluation
• Critical review of HTA publications
• Evidence synthesis
• Measuring and valuing health
• HTA decision models
• Industry HTA case studies
• Key statistical challenges in HTA
Course runs from: 10:00 – 18:00 (registration from 9:30) on Day 1
09:00 – 15:30 on Day 2.
Registration
Before 23rd December 2016
PSI Members
£495 + VAT
Non- Members
£570 + VAT (includes PSI membership for 1 year)
After 23rd December 2016
PSI Members
£595 +VAT
Non - Members
£670 + VAT (includes PSI membership for 1 year)
Registration costs (includes lunch and refreshments)
PSI are holding a limited number of hotel rooms at an extra cost until the 23rd December 2016 which will be allocated on a first come first served basis. Please contact the PSI Secretariat for more information.
Registration is now closed. Please contact the PSI Secretariat for late registrations.
Journal Club
Health Technology Assessment (HTA) Training Course
Presented by
Mark Sculpher, Neil Hawkins
and members of the HTA SIG
This 2-day course will provide an introduction to the methods of health technology assessment. There will be a focus on how to estimate the costs and benefits of new interventions and analysis undertaken to support decisions about whether new interventions should be funded by health systems. The first day will include sessions on policy context and basic economic evaluation methods, as well as lectures on health measurement and valuation for HTA, evidence synthesis and decision analysis. There will also be exercises to confirm participants’ understanding of key concepts. The second day will focus on sharing case studies and discussing key statistical challenges in HTA. Attendees will be encouraged to share their own HTA experiences.
The following topics will be covered: • HTA Policy
• Methods of economic evaluation
• Critical review of HTA publications
• Evidence synthesis
• Measuring and valuing health
• HTA decision models
• Industry HTA case studies
• Key statistical challenges in HTA
Course runs from: 10:00 – 18:00 (registration from 9:30) on Day 1
09:00 – 15:30 on Day 2.
Registration
Before 23rd December 2016
PSI Members
£495 + VAT
Non- Members
£570 + VAT (includes PSI membership for 1 year)
After 23rd December 2016
PSI Members
£595 +VAT
Non - Members
£670 + VAT (includes PSI membership for 1 year)
Registration costs (includes lunch and refreshments)
PSI are holding a limited number of hotel rooms at an extra cost until the 23rd December 2016 which will be allocated on a first come first served basis. Please contact the PSI Secretariat for more information.
Registration is now closed. Please contact the PSI Secretariat for late registrations.
Webinars
Health Technology Assessment (HTA) Training Course
Presented by
Mark Sculpher, Neil Hawkins
and members of the HTA SIG
This 2-day course will provide an introduction to the methods of health technology assessment. There will be a focus on how to estimate the costs and benefits of new interventions and analysis undertaken to support decisions about whether new interventions should be funded by health systems. The first day will include sessions on policy context and basic economic evaluation methods, as well as lectures on health measurement and valuation for HTA, evidence synthesis and decision analysis. There will also be exercises to confirm participants’ understanding of key concepts. The second day will focus on sharing case studies and discussing key statistical challenges in HTA. Attendees will be encouraged to share their own HTA experiences.
The following topics will be covered: • HTA Policy
• Methods of economic evaluation
• Critical review of HTA publications
• Evidence synthesis
• Measuring and valuing health
• HTA decision models
• Industry HTA case studies
• Key statistical challenges in HTA
Course runs from: 10:00 – 18:00 (registration from 9:30) on Day 1
09:00 – 15:30 on Day 2.
Registration
Before 23rd December 2016
PSI Members
£495 + VAT
Non- Members
£570 + VAT (includes PSI membership for 1 year)
After 23rd December 2016
PSI Members
£595 +VAT
Non - Members
£670 + VAT (includes PSI membership for 1 year)
Registration costs (includes lunch and refreshments)
PSI are holding a limited number of hotel rooms at an extra cost until the 23rd December 2016 which will be allocated on a first come first served basis. Please contact the PSI Secretariat for more information.
Registration is now closed. Please contact the PSI Secretariat for late registrations.
Careers Meetings
Health Technology Assessment (HTA) Training Course
Presented by
Mark Sculpher, Neil Hawkins
and members of the HTA SIG
This 2-day course will provide an introduction to the methods of health technology assessment. There will be a focus on how to estimate the costs and benefits of new interventions and analysis undertaken to support decisions about whether new interventions should be funded by health systems. The first day will include sessions on policy context and basic economic evaluation methods, as well as lectures on health measurement and valuation for HTA, evidence synthesis and decision analysis. There will also be exercises to confirm participants’ understanding of key concepts. The second day will focus on sharing case studies and discussing key statistical challenges in HTA. Attendees will be encouraged to share their own HTA experiences.
The following topics will be covered: • HTA Policy
• Methods of economic evaluation
• Critical review of HTA publications
• Evidence synthesis
• Measuring and valuing health
• HTA decision models
• Industry HTA case studies
• Key statistical challenges in HTA
Course runs from: 10:00 – 18:00 (registration from 9:30) on Day 1
09:00 – 15:30 on Day 2.
Registration
Before 23rd December 2016
PSI Members
£495 + VAT
Non- Members
£570 + VAT (includes PSI membership for 1 year)
After 23rd December 2016
PSI Members
£595 +VAT
Non - Members
£670 + VAT (includes PSI membership for 1 year)
Registration costs (includes lunch and refreshments)
PSI are holding a limited number of hotel rooms at an extra cost until the 23rd December 2016 which will be allocated on a first come first served basis. Please contact the PSI Secretariat for more information.
Registration is now closed. Please contact the PSI Secretariat for late registrations.
Upcoming Events
PSI Introduction to Industry Training (ITIT) Course - 2026/2027
An introductory course giving an overview of the pharmaceutical industry and the drug development process as a whole, aimed at those with 1-3 years' experience. It comprises of six 2-day sessions covering a range of topics including Research and Development, Toxicology, Data Management and the Role of a CRO, Clinical Trials, Reimbursement, and Marketing.
Joint PSI/EFSPI Visualisation SIG 'Wonderful Wednesday' Webinars
Our monthly webinar explores examples of innovative data visualisations relevant to our day to day work. Each month a new dataset is provided from a clinical trial or other relevant example, and participants are invited to submit a graphic that communicates interesting and relevant characteristics of the data.
The Book Club session will discuss a podcast episode where the host of the Power Hour, Adrienne Herbert, chats with Ros about his book, and the secrets that he learned from years of working in high-pressure newsrooms, and the ten elements of a good explanation and the seven steps you need to take to express yourself with clarity and impact.
Our monthly webinar series allows attendees to gain practical knowledge and skills in open-source coding and tools, with a focus on applications in the pharmaceutical industry. This month’s session, “Graphics Basics,” will introduce the fundamentals of producing graphics using the ggplot2 package.
Connecting the False Discovery Rate to Shrunk Estimates
A 1 hour online event, that includes a presentation followed by Q&A.
This talk will explore the “replication crisis” in science, focusing on how testing large numbers of hypotheses can lead to false positive findings. It introduces key statistical approaches—False Discovery Rate (FDR) and shrinkage methods—to address this issue, and explains their conceptual foundations and connections. The session will also highlight how these tools can be understood within an empirical-Bayesian framework, linking significance testing with effect size estimation.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
PSI Book Club: The AI Con – Joint with ASA Book Club
The Guardian described the authors of this book as refreshingly sarcastic! What is sold to us as AI, they announce, is just "a bill of goods": "A few major well-placed players are poised to accumulate significant wealth by extracting value from other people's creative work, personal data, or labour, and replacing quality services with artificial facsimiles."
PSI Book Club: Another Door Opens – Book Club Special Event
This is a Book Club Special Event in response to the changes in our industry and as a supportive move to create community and connection for those navigating redundancy and uncertainty. Read the book in advance of the book club session then join the zoom call to discuss ideas. There will be breakout groups to connect with others, exchange experiences of how the book has helped, and offer support.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
GSK - Statistics Director - Vaccines and Infectious Disease
We are seeking an experienced and visionary Statistics Director to join our Team and lead strategic statistical innovation across GSK’s Vaccines and Infectious Disease portfolio.
As a Senior Biostatistician I at ICON, you will play a pivotal role in designing and analyzing clinical trials, interpreting complex medical data, and contributing to the advancement of innovative treatments and therapies.
As a Statistical Programmer II at ICON, you will play a vital role in the development, validation, and execution of statistical programs to support clinical trial analysis and reporting.
As a Statistical Scientist at ICON, you will play a pivotal role in designing and analyzing clinical trials, interpreting complex medical data, and contributing to the advancement of innovative treatments and therapies.
We have an exciting opportunity for an Associate Director, Biostatistics to join a passionate team within Advanced Quantitative Sciences – Full Development.
: We have an exciting opportunity for an Associate Director (AD), Statistical Programming, to join a passionate team within Advanced Quantitative Sciences- Development.
Novartis - Senior Principal Statistical Programmer
We have an exciting opportunity for a Senior Principal Statistical Programmer, to join a passionate team within Advanced Quantitative Sciences – Development.
Pierre Fabre - Clinical Development Safety Statistics Expert M/F
We are seeking a highly skilled and proactive Clinical Development Safety Statistics Expert to join our Biometry Department and the Biometry Leadership Team based in Toulouse (31, Oncopole) or Boulogne (92).
Pierre Fabre - Lead Statistician – Real World Evidence -CDI- M/F
Pierre Fabre Laboratories are hiring a highly skilled and experienced Lead Statistician – Real World Evidence (RWE) to join the Biometry Department, part of the Data Science & Biometry Department, based in Toulouse (Oncopôle) or Boulogne.
Pierre Fabre - Lead Statistician- Clinical Trials M/F
We are seeking a highly skilled and experienced Lead Statistician in Clinical Trials to join our Biometry Department based in Toulouse (31, Oncopole) or Boulogne (92).
As a Senior Statistician at Viatris, you will take a leading role in designing clinical studies, guiding statistical strategy, and ensuring that statistical deliverables meet the highest scientific and regulatory standards.